Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM
暂无分享,去创建一个
Naveen Pemmaraju | R. Mesa | N. Pemmaraju | Vikas Gupta | M. Thompson | Vikas Gupta | J. Kiladjian | Audun Utengen | Jean-Jacques Kiladjian | Ruben Mesa | Michael A Thompson | Audun Utengen
[1] Tejas Desai,et al. Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends. , 2017, Journal of oncology practice.
[2] R. Mesa,et al. Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM , 2016, Current Hematologic Malignancy Reports.
[3] D. Asch,et al. Twitter as a Potential Data Source for Cardiovascular Disease Research. , 2016, JAMA cardiology.
[4] A. Lane,et al. Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) , 2016, Current Hematologic Malignancy Reports.
[5] Robert S. Miller,et al. Using social media in oncology for education and patient engagement. , 2012, Oncology.
[6] R. Mesa,et al. The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette. , 2017, Seminars in hematology.
[7] M. Markham,et al. Social Media for Networking, Professional Development, and Patient Engagement. , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[8] W. Wood,et al. Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer , 2016, Current Hematologic Malignancy Reports.
[9] M. Thompson. Using social media to learn and communicate: it is not about the tweet. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[10] Twitter 101 and beyond: introduction to social media platforms available to practicing hematologist/oncologists. , 2017, Seminars in hematology.
[11] Naveen Pemmaraju,et al. Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology. , 2017, Seminars in hematology.
[12] D. Murphy,et al. Activity, content, contributors, and influencers of the twitter discussion on urologic oncology. , 2016, Urologic oncology.
[13] W. Wood,et al. Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider , 2015, Current Hematologic Malignancy Reports.
[14] P. F. Anderson,et al. Disease-Specific Hashtags for Online Communication About Cancer Care. , 2016, JAMA oncology.
[15] R. Mesa,et al. Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM , 2015, Current Hematologic Malignancy Reports.
[16] Sean Ekins,et al. Ten Simple Rules of Live Tweeting at Scientific Conferences , 2014, PLoS Comput. Biol..
[17] N. Savage. Scientists in the Twitterverse , 2015, Cell.
[18] Raina M Merchant,et al. Cancer Communication in the Social Media Age. , 2016, JAMA oncology.
[19] Aafia Chaudhry,et al. Trends in twitter use by physicians at the american society of clinical oncology annual meeting, 2010 and 2011. , 2012, Journal of oncology practice.
[20] A. Nazha,et al. Impact of social media for the hematologist/oncologist. , 2017, Seminars in hematology.
[21] Robert S. Miller,et al. Practical guidance: the use of social media in oncology practice. , 2012, Journal of oncology practice.
[22] The emerging role of professional social media use in oncology. , 2017, Future oncology.